About this trial
ELDORA is a non-interventional observational data-science study aiming to develop and validate clinical-grade artificial intelligence tools applied to electrocardiogram (ECG) data. The project will standardize heterogeneous ECGs, create the ECGInsight harmonized database, and train interpretable models for life-threatening arrhythmia risk prediction, especially Torsades-de-Pointes/long QT syndrome and immune checkpoint inhibitor (ICI)-induced myocarditis. The project uses existing and ongoing national and international ECG cohorts with de-identified clinical metadata; AI outputs are intended for research/model development and are not used to drive patient care during the study.
Eligibility criteria
Qualifiers
subjects included in participating existing or ongoing ECG cohorts made available to ECGInsight
availability of ECG data (digital waveform or scanned/paper ECG suitable for digitization) and relevant clinical/demographic metadata
data use permitted by applicable ethical, regulatory, contractual and GDPR requirements.
Disqualifiers
datasets or individual records for which required approvals, data-sharing agreements, de-identification/anonymization, or minimum ECG/metadata quality requirements are not met. No interventional study treatment is assigned.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Groupe Hospitalier Pitie-Salpetriere
Lead sponsor
Institut de Recherche pour le Developpement
Collaborator
Institut National de la Santé Et de la Recherche Médicale, France
Collaborator
Vanderbilt University Medical Center
Collaborator
University of California, San Francisco
Collaborator
University Hospital, Bordeaux
Collaborator
Assistance Publique - Hôpitaux de Paris
Collaborator
Banook Group
Collaborator